LAMBERTUCCI, Catia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.846
EU - Europa 4.111
AS - Asia 1.092
Continente sconosciuto - Info sul continente non disponibili 32
SA - Sud America 9
AF - Africa 6
OC - Oceania 4
Totale 15.100
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.538
PL - Polonia 1.254
CN - Cina 981
IT - Italia 820
DE - Germania 505
UA - Ucraina 373
GB - Regno Unito 312
SE - Svezia 312
CA - Canada 307
FR - Francia 201
FI - Finlandia 167
IE - Irlanda 85
EU - Europa 32
BE - Belgio 26
VN - Vietnam 26
KR - Corea 19
IN - India 14
NL - Olanda 14
IR - Iran 13
RO - Romania 12
TR - Turchia 9
RU - Federazione Russa 7
SG - Singapore 7
AT - Austria 6
BR - Brasile 4
DK - Danimarca 4
JP - Giappone 4
LB - Libano 4
AU - Australia 3
CZ - Repubblica Ceca 3
GR - Grecia 3
HK - Hong Kong 3
DZ - Algeria 2
JO - Giordania 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BT - Bhutan 1
CH - Svizzera 1
CL - Cile 1
CM - Camerun 1
CO - Colombia 1
EC - Ecuador 1
ID - Indonesia 1
KE - Kenya 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 15.100
Salva come PNG Salva come JPEG
Città #
Fairfield 1.292
Woodbridge 1.112
Warsaw 1.098
Jacksonville 925
Chandler 731
Houston 679
Ashburn 639
Seattle 563
Wilmington 509
Ann Arbor 480
Cambridge 440
Nanjing 302
Toronto 221
Camerino 167
Kraków 152
San Mateo 138
Lawrence 128
Princeton 128
Dearborn 125
Boardman 110
Columbus 105
Ogden 104
Düsseldorf 101
Nanchang 101
Beijing 93
Dublin 84
Lachine 83
Helsinki 69
San Diego 63
New York 61
Shenyang 61
Kunming 59
London 57
Tianjin 53
Milan 47
Hebei 41
Centro 30
Ningbo 28
Brussels 26
Jinan 25
Changsha 24
Jiaxing 24
Dong Ket 23
Hefei 21
Norwalk 21
Verona 21
Falls Church 20
Hangzhou 20
Los Angeles 20
Redwood City 19
Orange 18
Philadelphia 18
Zhengzhou 18
Venezia 17
Guangzhou 16
Bremen 15
Shanghai 14
Tappahannock 13
Chicago 12
Detroit 12
Nürnberg 12
San Francisco 12
Taizhou 11
Hounslow 10
Indiana 10
New Bedfont 10
Washington 10
Acton 9
Leawood 9
Perugia 9
Ardabil 8
Auburn Hills 8
Changchun 8
Kilburn 8
Meppel 8
Scafati 8
Frankfurt am Main 7
Kocaeli 7
Lanzhou 7
Rome 7
Scuola 7
Seoul 7
Ascoli Piceno 6
Buffalo 6
Caserta 6
Council Bluffs 6
Horia 6
Varese 6
Alessandria 5
Ancona 5
Chengdu 5
Chiswick 5
Hanover 5
Pawcatuck 5
Portland 5
Americana 4
Augusta 4
Bologna 4
Cagliari 4
Ferrara 4
Totale 11.879
Salva come PNG Salva come JPEG
Nome #
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 320
Overview on Radiolabel-Free in Vitro Assays for GPCRs 308
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 253
2’,3’-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 242
The G Protein-Coupled Receptor GPR17: Overview and Update 240
Pharmacological characterization of the GPR17 receptor dual profile 235
A2AR agonists/A3R antagonists: design, synthesis, and biological evaluation of new ligands with dual activity 233
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemia 203
Adenine based acyclic-nucleotides as novel P2X3 receptor ligands 201
8-(2-Furyl)adenine derivatives as A2A adenosine receptor ligands 198
Investigation on 2′,3′-O-Substituted ATP Derivatives and Analogs as Novel P2X3 Receptor Antagonists 196
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 186
GPR17 receptor modulators and their therapeutic implications: review of recent patents 181
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 173
Human cytidine deaminase: understanding the catalytic mechanism 172
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 169
Approaches for designing and discovering purinergic drugs for gastrointestinal diseases 169
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 162
Purine and deazapurine nucleosides: synthetic approaches, molecular modeling and biological activity 160
Levels of polychlorinated biphenyls in fish and shellfish from the Adriatic Sea 156
Design, synthesis, and biological evaluation of new mitonafide derivatives as potential antitumor drugs 156
Fragment optimization for GPCRs by molecular dynamics free energy calculations: Probing druggable subpockets of the A2A adenosine receptor binding site 153
Synthesis of a conformationally restricted analogue of paclitaxel 151
Purinergic Ligands as Potential Therapeutic Tools for the Treatment of Inflammation-Related Intestinal Diseases 151
Ex-vivo absorption study of lysine R-lipoate salt, a new pharmaceutical form of R-ALA 150
New sensible method to quantize the intestinal absorption of receptor ligands 149
3'-Deoxyribofuranose derivatives of 1-deaza and 3-deaza adenosine and their activity as adenosine deaminase inhibitors 148
Comparison and optimization of transient transfection methods at human astrocytoma cell line 1321N1 147
“Third Joint Italian-German Purine Club Meeting - Purinergic Receptors: New Frontiers for Novel Therapies” 147
Structure-activity relationships of adenine and deazaadenine derivatives as ligands for adenine receptors, a new purinergic receptor family 147
Adenine and deazaadenine nucleoside and deoxynucleoside analogues: inhibition of viral replication of sheep MVV (in vitro model for HIV) and bovine BHV-1 145
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 144
9-ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities 144
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 144
Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors 143
Non-Nucleoside Agonists of the Adenosine Receptors: An Overview 143
Adenosine deaminase: Functional implications and different classes of inhibitors 142
Frontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor. 142
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 142
A taxane epoxide from taxus wallichiana 142
Biomarkers Mapping in a Neuropathic Pain Mice Model with Sciatic Nerve Chronic Constriction Injury (CCI). 142
Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model 142
Molecular modeling studies on the human neuropeptide S receptor and its antagonists. 141
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 141
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 141
Synthesis and NMR-Driven Conformational Analysis of Taxol Analogues Conformationally Constrained on the C13 Side Chain 140
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor 140
The importance of alkynyl chain presence for the activity of adenine nucleosides/nucleotides on purinergic receptors 139
The aminopyridine-3,5-dicarbonitrile core for the design of new non-nucleoside-like agonists of the human adenosine A2B receptor 139
Solid phase synthesis and antiprotozoal evaluation of di- and trisubstituted 5 '-carboxamidoadenosine analogues 138
Identification of alpha(1)-adrenoceptor subtypes involved in contraction of young CD rat epididymal vas deferens 137
Ring opening reactions: synthesis of AICAR analogs as potential antimetabolite agents 137
GPCRs as therapeutic targets: a view on adenosine receptors structure and functions, and molecular modeling support 137
Pharmacological postconditioning of the rabbit heart with non-selective, A1, A2A and A3 adenosine receptor agonists 135
Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor 133
Synthesis and evaluation of hexitol nucleoside congeners as ambiguous nucleosides 132
Coupling of 2,6-disubstituted purines to ribose-modified sugars 130
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 130
Update on novel purinergic P2X3 and P2X2/3 receptor antagonists and their potential therapeutic applications 130
Antiviral properties of deazaadenine nucleoside derivatives 128
Synthesis, structure-affinity relationships and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 126
8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A(2A) and A(2B) receptors ligands 126
Pyrazolo[1,5-c]quinazoline derivatives and their simplified analogues as adenosine receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies 124
New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile 123
Adenosine receptor modeling: what does the A2A crystal structure tell us? 123
Synthesis and adenosine receptor affinity and potency of 8-alkynyl derivatives of adenosine 123
Synthesis and stability studies of 2 ',3 ',5 '-tri-O-acetyl-2-amino(-N-6-cyclopentyl)-1-deazaadenosines 122
Purine nucleosides bearing 1-alkynyl chains as adenosine receptor agonists 121
A(2A) Adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists 119
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 115
Probing ambiguous base-pairs by genetic transformation with XNA templates 114
Effects of 5 '-phosphate derivatives of 2-hexynyl adenosine and 2-phenylethynyl adenosine on responses of human platelets mediated by P2Y receptors 114
2- And 8- alkynyladenosines: conformational studies and docking to human adenosine A(3) receptor can explain their different biological behavior 106
Human adenosine A3 receptor as selective target of new 2-aralkynyl-N6-methyl-MECA derivatives 106
Synthesis of new nucleosides by coupling of chloropurines with 2- and 3-deoxy derivatives of N-methyl-D-ribofuranuronamide 104
The Chemistry and Occurrence of Taxane Derivatives. XXVI. A Reactivity Study on 11(15→1)Abeotaxanes 104
2-substituted 5 '-N-methylcarboxamidoadenosine (MECA) derivatives as A(3) adenosine receptor ligands 101
A(2A) adenosine receptor agonists reduce both high-palatability and low-palatability food intake in female rats 99
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 99
The Anti-Inflammatory and Pain-Relieving Effects of AR170, an Adenosine A3 Receptor Agonist, in a Rat Model of Colitis 99
Adenosine A(2A) receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's disease 97
N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands 97
Adenosine receptor agonists:synthesis and binding affinity of 2-(aryl)alkylthioadenosine derivatives 97
N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A(3) adenosine receptor 96
A(2B) adenosine receptor agonists: synthesis and biological evaluation of 2-phenylhydroxypropynyladenosine and NECA derivatives 96
New potent and selective A1 adenosine receptor antagonists as potential tools for the treatment of gastrointestinal diseases 95
[3H]HEMADO – a novel tritiated agonist selective for the human adenosine A(3) receptor 93
Synthesis and biological evaluation of 2-alkynyl-N6-methyl-5'-N-methylcarboxamidoadenosine derivatives as potent and highly selective agonists for the human adenosine A(3) receptor 92
Highlights on the development of A(2A) adenosine receptor agonists and antagonists 91
2-phenylhydroxypropynyladenosine derivatives as high potent agonists at A(2B) adenosine receptor subtype 90
Purinergic P2X receptors: Structural models and analysis of receptor-ligand interaction 90
Synthetic procedure for the preparation of novel potent and selective A(3) adenosine receptor radioligands 88
2- And 8-alkynyl-9-ethyladenines: Synthesis and biological activity at human and rat adenosines receptors 88
Synthesis and biological activity of trisubstituted adenines as A(2A) adenosine receptor antagonists 87
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 83
9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution result in distinct selectivities. 80
Development of new chromatographic tools based on Adenosine A2A subtype receptor for ligand characterization and screening by FAC-MS 79
Sintesi di analoghi del paclitaxel vincolati conformazionalmente 78
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A Antagonists 77
Deaza- and deoxyadenosine derivatives: synthesis and inhibition of animal viruses as human infectious models 76
Totale 13.857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.190
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.190
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019971 0 0 0 0 0 0 0 0 0 171 360 440
2019/20203.493 429 161 337 668 206 293 248 328 231 227 120 245
2020/20213.131 127 249 179 237 161 376 623 71 273 155 429 251
2021/20221.617 185 407 34 40 76 81 92 123 122 175 109 173
2022/20231.747 194 114 45 300 172 245 8 104 304 103 108 50
2023/2024925 182 72 93 62 64 125 54 91 158 24 0 0
Totale 15.452